Drug companies control news with $$$$ in ads The Deeper

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
105
Drug companies control news with $$$$ in ads

The Deeper Reason For Drug Ads On Television

https://www.naturalblaze.com/2018/03/deeper-r...ision.html

By Jon Rappoport

Television viewers are inundated with drug ads from Big Pharma. It’s a flood.

Have you ever heard of these drugs? Otezla, Xeljanz, Namzaric, Keytruda, Breo, Cosentyz? Not likely. If you have, do you know what conditions they treat? Highly unlikely. But there they are, splashed in commercials.

Why? Who is going to remember to ask their doctor whether these and other obscure meds are right for them?

What’s going on here?

The answer is: IT DOESN’T MATTER WHAT DRUGS ARE BEING ADVERTISED.

If Pharma can pay enough TOTAL money for ads, for ALL drugs, and dominate the allotted TV time for commercials, it can control the news—and that is exactly what it wants to do.

Pharmaceutical scandals are everywhere. Reporting on them, wall to wall, isn’t good for the drug business. However, as an industry ponying up billions of dollars for TV ads, Pharma can limit exposure and negative publicity. It can (and does) say to television networks: If you give us a hard time on the news, we’ll take our ad money and go somewhere else. Boom. End of problem.

Face it, the billions of dollars Pharma is paying for TV ads are a drop in the bucket, compared with its profits gained from selling the drugs. The ads are a good investment. As a bribe.

Control the news.

There is another reason for the insane flood of TV drug ads:

By their sheer number, they convince viewers that medical drugs (no matter what they are) are absolutely necessary.

Hour by hour, viewers numbly watch drug commercial after commercial. The overall message is: To keep illness from your door, to cure illness, to alleviate illness, you must take these medicines. THIS IS LIFE IN THE 21ST CENTURY. You’re all sick, and you need help, and this is the ONLY kind of help there is.

The drug companies could invent names of fake drugs that don’t even exist, advertise them in a cascade on television, with the same intent. DRUGS ARE AS VITAL TO LIFE AS WATER OR AIR.
But what about all those dire warnings of side effects from the drugs? By law, the companies must include them in their commercials. Well, the companies have calculated that, on balance, the stark, front-line, unending message of DRUGS, DRUGS, AND MORE DRUGS will outweigh the warnings in viewers’ minds.

If the television audience is nailed with the idea that they can’t escape; that their health always hangs in the balance; that dire illnesses are always waiting in the shadows to strike; that the slightest ache or pain could be a precursor to a crippling or fatal disease; and drugs are the only solution and protection—they’re going to overlook the warnings about side effects.

ALL IN ALL, DRUG ADS ARE NEWS.

That’s the approach. Pharma is blasting out 24/7 news asserting modern medicine’s central and commanding role in the life of every human.

It’s a gigantic and stupendous piece of mind control, but when did that ever stop tyrants from inventing reality for the masses?

Implicit in “ask your doctor if drug X is right for you,” is the message: “go to your doctor.” That’s the key. If the ads can put a viewer into the system, he will be diagnosed with something, and he’ll be given a drug for it.

So the drug ads are also promotions for doctors, who are the arbiters and the decision makers. Some kind of medical need (drugs) always exists—and the doctor will tell you what it is. And all patients should OBEY. Even if, in the process, they go broke.

Take the case of Opdivo, a drug that treats squamous non-small cell lung cancer. Cost? $12,500 a month. Patients on Medicare will pay $2500 a month out of their own pockets. And the result?

Wall St. Journal: “In the clinical study on which the Opdivo ad bases its claims, the drug extended median patient survival to 9.2 months from the start of treatment…”

The cancer patient pays $22,500 for nine months of survival, during which the suffering continues, and then he dies.

The ad isn’t mentioning THAT.

The ad relies on the doctor to convince the patient to go along with this lunatic program.

The author of two explosive collections, THE MATRIX REVEALED and EXIT FROM THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free emails at www.nomorefakenews.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GARDANT Expands Reach with International Partnership

Updated Category News Views 0

GARDANT Global's Strategic Expansion Well, today we saw GARDANT Global make a move that screams ambition. They’re hooking up with International Offset Corporation (IOC) to muscle up their game in the murky waters of government procurement. Why does this matter? Because it's all about who gets the contracts, and with GARDANT’s newfound reach, they’re not just...

Continue Reading
Infinite Electronics Reveals Cutting-Edge Connectivity at Electronica

Updated Category News Views 143

Infinite Electronics Makes Waves at Electronica 2026 Let’s get down to brass tacks: Infinite Electronics is setting up one heck of a show at the electronica 2026 in Munich from November 10–13. They're not just there to give out free pens—these guys mean business with connectivity products that cover everything from drones to industrial automation. A Showcase of...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 81

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
Max Stock Gears Up for Q3 Earnings Report Nov. 17

Updated Category News Views 61

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Continue Reading
HR HealthCare Foundation: New Chapter of Giving

Updated Category News Views 6

HR HealthCare Reaffirms Commitment Through New Foundation The corporate world didn't see this one coming. On October 29, 2026, HR HealthCare, a stalwart in the healthcare products arena, has decided to double down on its benevolent side by establishing the HR HealthCare Foundation. It ain't just about selling widgets anymore; it's about making a genuine impact outside the...

Continue Reading
Thunderly Bags Davey Awards for Creative Franchise Videos

Updated Category News Views 47

Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 152

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
ODNB and NACB Merge: A Big Leap in Community Banking

Updated Category News Views 65

Merging Titans in Community Banking Folks, we've got a colossal merger happening in the cozy yet combative world of community banking—ODNB Financial Corporation is hitching wagons with National Capital Bancorp, Inc. Now, you'd be forgiven for not popping champagne over this unless your bread is buttered by $2.4 billion in assets and the shiny allure of becoming a big...

Continue Reading
From Missouri to Market: A New Spin on Turkey Calls

Updated Category News Views 24

Innovating the Turkey Call Game You want innovation? Well, wrap your head around this: a Missouri inventor is flipping the script on turkey mouth calls. The goal? To ditch the wrinkles and make turkey hunting that much smoother. It might seem a bit niche, but when you've been around long enough, you know these 'niche' ideas can sometimes hatch golden eggs for investors....

Continue Reading
CaringKind Merger Expands Alzheimer's Care in NY

Updated Category News Views 19

A New Chapter for Dementia Care: The CaringKind Merger Cornerstone local relationships plus a fresh westerly breeze of national presence—that's the gist of the recent union between CaringKind and Alzheimer's Disease Resource Center. This isn't just a big deal for families in Nassau and Suffolk counties, it's a seismic shift for dementia care reaching across state...

Continue Reading

Top 5 Most Recently Viewed Articles

CCM Hockey Partners with CSSHL to Elevate Young Athletes

Updated Category News Views 133

Announcing an Exciting Collaboration The Canadian Sport School Hockey League (CSSHL) has forged a new and extensive partnership with CCM Hockey, one of the most renowned brands in ice hockey. This collaboration marks a significant milestone as CCM becomes the Exclusive On-and-Off-Ice Supplier for the CSSHL. Importance of this Partnership This partnership unites two...

Continue Reading
Regions Bank Lowers Prime Rate to Boost Borrowing Capacity

Updated Category News Views 60

Regions Bank Lowers Prime Lending Rate In a move aimed at improving borrowing options, Regions Bank has officially reduced its prime lending rate from 8.50% to a more appealing 8.00%. This important change is set to take effect soon, as the bank looks to provide enhanced financial solutions for its customers. Why the Rate Reduction is Important This decision to cut the...

Continue Reading
SolarBank Ventures into Booming Data Center Sector

Updated Category News Views 103

SolarBank's Strategic Entry into the Data Center Market SolarBank Corporation (NASDAQ: SUUN), a pioneer in sustainable energy solutions, is gearing up to engage with the rapidly expanding data center industry. As demand for cloud computing and advanced technologies continues to surge, SolarBank recognizes the critical need for high-performance energy solutions within this...

Continue Reading
Penetron Strengthens Midwest, Central USA Support Team

Updated Category News Views 13

Expansion of Penetron's Engineering Support Eyes are on the Midwest and Central USA as Penetron makes a strategic move to bolster their technical support dream team. They've snagged Sean Allison, a heavyweight with more than three decades' worth of grit and know-how from the construction battlefield. Sean, now stationed in the heart of America's Dairyland—Green Bay,...

Continue Reading
Salesfloor Expands Its Reach with Clientela Acquisition

Updated Category News Views 484

Strategic Acquisition Marks a New Chapter for Salesfloor Salesfloor, a leader in Clienteling and virtual shopping solutions, has recently taken a significant step forward by acquiring Clientela. This strategic acquisition expands Salesfloor’s market reach and enhances its already robust platform, aimed at engaging customers with cutting-edge technology. Enhancing...

Continue Reading